Emerging respiratory infections: influenza, MERS-CoV, and extensively drug-resistant tuberculosis

Lancet Respir Med. 2014 Dec;2(12):970-2. doi: 10.1016/S2213-2600(14)70250-4. Epub 2014 Nov 19.

Authors

Ellen Fragaszy¹, Andrew Hayward²

Affiliations

¹ Farr Institute of Health Informatics Research, University College London, 222 Euston Road, London NW1 2DA, UK.
² Farr Institute of Health Informatics Research, University College London, 222 Euston Road, London NW1 2DA, UK. Electronic address: a.hayward@ucl.ac.uk.

No abstract available

MeSH terms

Adult
Child
Communicable Diseases, Emerging / epidemiology*
Coronavirus Infections / epidemiology*
Extensively Drug-Resistant Tuberculosis / epidemiology*
Global Health
Humans
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H7N9 Subtype
Influenza, Human / epidemiology*
Middle East Respiratory Syndrome Coronavirus
Tuberculosis, Pulmonary / epidemiology*

Grants and funding